top of page
BPIQ Blog
Aug 26, 20221 min read
Free Biopharma Daily Pulse - 08/26/22
$XBI $85.04 | -4.85% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 26, 20221 min read
Free Biopharma Daily Pulse - 08/26/22
$XBI $85.04 | -4.85% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 15, 20221 min read
Biopharma Daily Pulse - 08/15/22
$XBI $94.90 | +1.19% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 15, 20221 min read
Free Biopharma Daily Pulse - 08/15/22
$XBI $94.90 | +1.19% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 15, 20221 min read
Biopharma Mid Morning Pulse - 08/15/22
(Posted 10:50am CST) $XBI $94.05 | +0.29% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume...
Aug 15, 20221 min read
Free Biopharma Mid Morning Pulse - 08/15/22
(Posted 10:50am CST) $XBI $94.05 | +0.29% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume...
Jul 13, 20221 min read
Biopharma Mid Morning Pulse - 07/13/22
(Posted 9:55am CST) $XBI $83.17 | +1.59% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 13, 20221 min read
Free Biopharma Mid Morning Pulse - 07/13/22
(Posted 9:55am CST) $XBI $83.17 | +1.59% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 1, 20222 min read
Biopharma Pulse - 6/27-7/1 Week in Review
As we reach the end of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...
Jun 30, 20222 min read
Biopharma Daily Stock Updates - 06/30/22
$XBI $74.27 | -0.71% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #HGEN -4% NIH/NIAID Locks...
Jun 30, 20222 min read
Free Biopharma Daily Stock Updates - 06/30/22
$XBI $74.27 | -0.71% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #HGEN -4% NIH/NIAID Locks...
Jun 10, 20223 min read
Biopharma Daily Stock Updates - 06/10/22
$XBI $67.03 | -4.60% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #GRTS -0.4% Gritstone Announces...
Jun 10, 20223 min read
Free Biopharma Daily Stock Updates - 06/10/22
$XBI $67.03 | -4.60% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #GRTS -0.4% Gritstone Announces...
Jun 6, 20224 min read
Biopharma Daily Stock Updates - 06/06/22
$XBI $69.18 | -2.85% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #CYCN +8.6%...
Jun 6, 20224 min read
Free Biopharma Daily Stock Updates - 06/06/22
$XBI $69.18 | -2.85% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates # Pipeline Updates #CYCN +8.6%...
Dec 31, 20212 min read
J.P. Morgan Healthcare Conference
The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...
Jun 22, 20214 min read
COVID-19 Therapeutic Stocks to Watch (June 2021)
Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...
Jun 13, 20214 min read
AMRN - Supreme Court Cert Decision June 21
6/21/21 Update. As was predicted by Dr. Vacchiano in his articles on BPIQ.com, the Supreme Court DENIED AMRN's Petition for Cert. This...
Nov 14, 20194 min read
AMRN - Near-Term Price Acton Depends on Breadth of Label, but Acquisition Chatter and Quarterly Resu
Today, an advisory committee appointed by the FDA met and voted to recommend to the FDA that it expands the label for AMRN's...
Nov 30, 20182 min read
Amarin's U.S. Patent Protection For Vascepa
Download Full Article Summary Amarin has patent protection for Vascepa® out to 2030, including protection related to the possible...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page